Division of Cardiothoracic Surgery, New York Presbyterian Hospital, Columbia College of Physicians and Surgeons, New York, NY, USA.
J Heart Lung Transplant. 2012 Mar;31(3):266-73. doi: 10.1016/j.healun.2011.10.004. Epub 2011 Nov 16.
No standard index based on donor factors exists for predicting mortality after orthotopic heart transplantation (OHT). We utilized United Network for Organ Sharing (UNOS) data to develop a quantitative donor risk score for OHT.
We examined a prospectively collected open cohort of 22,252 patients who underwent primary OHT (1996 to 2007). Of the 284 donor-specific variables, those associated with 1-year (year) mortality (exploratory p-value < 0.2) were incorporated into a multivariate (MV) logistic regression model. The final model contained donor factors that improved the explanatory power (by pseudo-R2, area under the curve and likelihood ratio test). A quantitative donor risk score was created using odds ratios (ORs) from the final model. For external validity, a cross-validation strategy was employed whereby the score was generated using a randomly generated subset of cases (n = 17,788) and then independently validated on the remaining patients (n = 4,464).
A 15-point scoring system incorporated 4 variables: ischemic time; donor age; race mismatching; and blood urea nitrogen (BUN)/creatinine ratio. Derivation and validation cohort scores ranged from 1 to 15 and 1 to 12, respectively (mean 4.0 ± 2.1 for each). Each increase of 1 point increased the risk of 1-year death by 9% (OR = 0.09 [1.07 to 0.12]) in the derivation cohort and 13% (OR = 0.13 [1.08 to 0.18]) in the validation cohort (each p < 0.001). The odds of 1-year mortality by increments of 3 points were: 0 to 2 points (reference); 3 to 5 points (OR = 0.25 [1.12 to 0.40], p < 0.001); 6 to 8 pts (OR = 0.77 [1.56 to 2.02], p < 0.001); and 9 to 15 points (OR = 1.92 [1.54 to 2.39], p < 0.001). Donor risk score was predictive for 30-day mortality (OR = 0.11 [1.08 to 0.14], p < 0.001) and 5-year cumulative mortality (OR = 0.11 [1.09 to 0.13], p < 0.001).
We present a novel donor risk index for OHT predicting short- and long-term mortality. This donor risk score may prove valuable for donor heart allocation and prognosis after OHT.
目前尚不存在基于供体因素的预测原位心脏移植(OHT)后死亡率的标准指数。我们利用美国器官共享联合网络(UNOS)的数据,制定了一个用于 OHT 的供体风险定量评分。
我们检查了一个前瞻性收集的 22252 例接受初次 OHT(1996 年至 2007 年)的患者的开放队列。在 284 个供体特异性变量中,那些与 1 年死亡率相关的变量(探索性 p 值<0.2)被纳入多变量(MV)逻辑回归模型。最终模型包含可提高解释能力的供体因素(通过伪 R2、曲线下面积和似然比检验)。使用最终模型中的优势比(OR)创建了一个定量供体风险评分。为了验证外部有效性,采用了交叉验证策略,即用随机生成的病例子集(n=17788)生成评分,然后在剩余的 4464 例患者中独立验证评分。
15 分评分系统纳入了 4 个变量:缺血时间、供体年龄、种族不匹配和血尿素氮/肌酐比值。推导和验证队列的评分范围分别为 1 至 15 和 1 至 12(每个队列的平均值为 4.0±2.1)。在推导队列中,每增加 1 分,1 年死亡的风险增加 9%(OR=0.09[1.07 至 0.12]),在验证队列中增加 13%(OR=0.13[1.08 至 0.18])(均<0.001)。1 年死亡率按 3 分增量的概率为:0 至 2 分(参考);3 至 5 分(OR=0.25[1.12 至 0.40],<0.001);6 至 8 分(OR=0.77[1.56 至 2.02],<0.001);9 至 15 分(OR=1.92[1.54 至 2.39],<0.001)。供体风险评分可预测 30 天死亡率(OR=0.11[1.08 至 0.14],<0.001)和 5 年累积死亡率(OR=0.11[1.09 至 0.13],<0.001)。
我们提出了一种新的 OHT 供体风险指数,可预测短期和长期死亡率。该供体风险评分可能对 OHT 后的供体心脏分配和预后具有重要价值。